Immunopharmacology and Inflammation
暫譯: 免疫藥理學與發炎反應

本書全面概述了當前在炎症與免疫藥理學方面的研究，特別關注抗炎藥物的使用，並討論了該藥理研究領域的未來趨勢。內容針對具備基本炎症過程、免疫系統及藥理學知識的讀者。本書滿足研究生、初級及高級研究人員的需求，並為已在這些領域工作的專業人士提供最新資訊的來源。

Carlo Riccardi is full professor of Pharmacology at the Perugia University Medical School, Italy, and currently the Director of the Department of Medicine. Prof. Riccardi completed both his Pharmacy and Medical degrees at the University of Perugia, and a period as a Research Associate, at the Department of Pathology, State University of New York at Buffalo. He was also Guest Visitor in the Laboratory of Immunodiagnosis, N.C.I., N.I.H., in Bethesda, Maryland. His field of research is the immunopharmacology, with a particular focus on the molecular mechanisms of action of glucocorticoids in inflammation and the mechanisms regulating the lymphocyte activation, growth and differentiation. These studies have been the subject of more than 270 publications in international journals. He participated to numerous congresses and meetings worldwide as invited speaker and/or chairman for his competences in Pharmacology, Inflammation and Immunology, Glucocorticoids, Apoptosis, Cell Growth Regulation, GILZ and GITR. He is member of the Editorial Board and referee of many international scientific Journals. He is also member of many scientific societies, such as International Association of Inflammation Societies, IUPHAR, and Italian Society of Pharmacology, of which he has been President. Throughout his career, he has obtained several grants to develop and work in the research field of pharmacology.

Francesca Levi-Schaffer is a Professor at The Hebrew University of Jerusalem Institute for Drug Research, School of Pharmacy, Faculty of Medicine. She holds the Isaac and Myrna Kaye Chair in Immunopharmacology. Prof. Levi-Schaffer was born in Italy and completed her PharmD degree at the University of Milano, her PhD degree in Immunology at the Weizmann Institute, Israel, and her post-doctorate at Harvard Medical School. Prof. Levi-Schaffer has published 160 articles in peer-reviewed journals, 83 reviews and editorials and 25 book chapters. She has two patents and one provisional patent. She is Chairperson of the National Committee of IUPHAR representing the Israel Academy of Sciences and Humanities, was instrumental in the establishment of an Immunopharmacology Section in the IUPHAR and currently serves as its first Chairperson. She is a member of the Israeli Ministry of Health Committee for Human Experimentation of New Drugs; a Councilor and member of the IUPHAR Executive Committee; member of the Board, treasurer (2016-18), and Secretary General (2018-20) of World Allergy Organization; and Council member of Collegium Internationale Allergologicum.

Prof. Levi-Schaffer's expertise is in immunopharmacology of allergy focusing on mast cells and eosinophils, their activating and inhibitory receptors, their cross-talk for a better prophylaxis/treatment of allergic diseases.

Ekaterini Tiligada graduated from University College Cardiff, UK, received her PhD from University of Wales College of Medicine, UK. She subsequently joined the Medical School, National and Kapodistrian University of Athens, Greece, where she is currently Professor of Experimental Pharmacology and coordinates the Immunopharmacology group.

During the last 25 years she has focused her research on inflammatory and immune-related processes, with particular interest in the functional role of histamine and histamine receptors in human pathophysiology. Her other areas of interest include the cellular stress response and drug hypersensitivity reactions. She has published over 100 peer reviewed papers and 10 book chapters. She has an extensive experience in teaching undergraduate and postgraduate medical and dental students and in training and supervising young researchers. She is currently Council Officer of the European Histamine Research Society, Treasurer of the IUPHAR Immunopharmacology Section and Observer in the Rheumatology-Immunology Working Party of the European Medicines Agency.

Carlo Riccardi 是義大利佩魯賈大學醫學院的藥理學全職教授，目前擔任醫學系主任。Riccardi 教授在佩魯賈大學完成了藥學和醫學學位，並在紐約州立大學水牛城分校的病理學系擔任研究助理。他還曾在馬里蘭州的貝塞斯達國立衛生研究院(N.C.I., N.I.H.)的免疫診斷實驗室擔任客座研究員。他的研究領域是免疫藥理學，特別專注於糖皮質激素在炎症中的分子作用機制以及調節淋巴細胞活化、增長和分化的機制。這些研究已在國際期刊上發表了超過270篇文章。他作為受邀演講者和/或主席參加了全球多個會議，並在藥理學、炎症和免疫學、糖皮質激素、細胞凋亡、細胞增長調控、GILZ 和 GITR 等領域擁有專業知識。他是多本國際科學期刊的編輯委員會成員和審稿人，並且是多個科學學會的成員，如國際炎症學會聯合會(IUPHAR)和義大利藥理學會，曾擔任該學會的會長。在他的職業生涯中，他獲得了多個研究經費，以發展和從事藥理學研究領域的工作。

Francesca Levi-Schaffer 是耶路撒冷希伯來大學藥物研究所的教授，隸屬於醫學院的藥學系。她擔任以撒和米爾娜·凱伊免疫藥理學講座教授。Levi-Schaffer 教授出生於義大利，在米蘭大學獲得藥學博士學位，並在以色列魏茨曼科學研究所獲得免疫學博士學位，隨後在哈佛醫學院完成博士後研究。Levi-Schaffer 教授在同行評審期刊上發表了160篇文章、83篇綜述和社論以及25章書籍章節。她擁有兩項專利和一項臨時專利。她是 IUPHAR 國家委員會的主席，代表以色列科學與人文學院，並在 IUPHAR 中建立了免疫藥理學分會，現任其首任主席。她是以色列衛生部新藥人體實驗委員會的成員；IUPHAR 執行委員會的理事和成員；世界過敏組織的董事會成員、財務主管（2016-2018）和秘書長（2018-2020）；以及國際過敏學會的理事會成員。

Levi-Schaffer 教授的專長是過敏的免疫藥理學，專注於肥大細胞和嗜酸性粒細胞及其活化和抑制受體，並研究它們之間的交互作用，以改善過敏疾病的預防和治療。

Ekaterini Tiligada 畢業於英國卡迪夫大學，並在威爾斯醫學院獲得博士學位。隨後，她加入希臘國立和卡波迪斯特里亞大學的醫學院，目前擔任實驗藥理學教授並協調免疫藥理學小組。

在過去的25年中，她專注於炎症和免疫相關過程的研究，特別關注組胺及其受體在人類病理生理學中的功能角色。她的其他研究興趣包括細胞壓力反應和藥物過敏反應。她已發表超過100篇同行評審的論文和10章書籍章節。她在教學本科和研究生醫學及牙科學生方面擁有豐富的經驗，並在培訓和指導年輕研究人員方面也有廣泛的經歷。她目前是歐洲組胺研究學會的理事，IUPHAR 免疫藥理學分會的財務主管，以及歐洲藥品管理局風濕病學-免疫學工作組的觀察員。